ATE334697T1 - Boviner atmungs- und darmcoronavirus als impfstoff - Google Patents

Boviner atmungs- und darmcoronavirus als impfstoff

Info

Publication number
ATE334697T1
ATE334697T1 AT98907727T AT98907727T ATE334697T1 AT E334697 T1 ATE334697 T1 AT E334697T1 AT 98907727 T AT98907727 T AT 98907727T AT 98907727 T AT98907727 T AT 98907727T AT E334697 T1 ATE334697 T1 AT E334697T1
Authority
AT
Austria
Prior art keywords
coronavirus
vaccine
bovine respiratory
intestine
bovine
Prior art date
Application number
AT98907727T
Other languages
English (en)
Inventor
Lisa C Stine
Michael J Mcginley
Gary A Anderson
Douglas L Stine
Karen K Brown
Andre D Dory
Adrian Liem
Original Assignee
Bayer Corp
Immtech Biolog Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp, Immtech Biolog Llc filed Critical Bayer Corp
Application granted granted Critical
Publication of ATE334697T1 publication Critical patent/ATE334697T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98907727T 1997-03-10 1998-03-04 Boviner atmungs- und darmcoronavirus als impfstoff ATE334697T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81431197A 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
ATE334697T1 true ATE334697T1 (de) 2006-08-15

Family

ID=25214684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907727T ATE334697T1 (de) 1997-03-10 1998-03-04 Boviner atmungs- und darmcoronavirus als impfstoff

Country Status (13)

Country Link
EP (1) EP0975360B1 (de)
JP (1) JP2001519781A (de)
KR (1) KR100531491B1 (de)
CN (1) CN1283315C (de)
AT (1) ATE334697T1 (de)
AU (1) AU725439B2 (de)
BR (1) BR9808226A (de)
CA (1) CA2231591A1 (de)
DE (1) DE69835424T2 (de)
DK (1) DK0975360T3 (de)
ES (1) ES2270508T3 (de)
NZ (1) NZ337702A (de)
WO (1) WO1998040097A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
KR20050048539A (ko) * 2001-10-06 2005-05-24 메리얼엘엘씨 ＣｐＧ 제제 및 관련된 방법
CN102021147B (zh) * 2003-03-24 2016-08-03 港大科桥有限公司 引起严重急性呼吸道综合征(sars)的新型人病毒及其应用
CN100543132C (zh) * 2003-03-24 2009-09-23 香港大学 引起严重急性呼吸道综合征(sars)的新型人病毒及其应用
EP1649053A4 (de) * 2003-06-18 2006-10-18 Chinese Nat Human Genome Ct Sh Charakterisierung der frühesten stufen des virus des schweren akuten respiratorischen syndroms (sars) und verwendungen davon
CN1318580C (zh) * 2003-07-10 2007-05-30 北京科兴生物制品有限公司 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法
US8440203B2 (en) 2009-11-06 2013-05-14 Intervet Inc. Methods of immunizing pregnant heifers at three months of gestation
MX379510B (es) 2014-09-03 2025-03-10 Intervet Int Bv Coronavirus bovino atenuado y vacunas relacionadas.
CN111117975A (zh) * 2020-01-03 2020-05-08 西南民族大学 牛冠状病毒he基因重组株及其制备的灭活疫苗和应用
CN113322241B (zh) * 2021-05-14 2023-06-13 金宇保灵生物药品有限公司 一种牛副流感病毒3型病毒株bpiv3-nm及其应用
CN117286111B (zh) * 2023-03-13 2024-06-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 牛冠状病毒分离株、稳定表达牛冠状病毒n蛋白细胞系及在构建反向遗传操作系统中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580778A (en) * 1994-06-15 1996-12-03 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
WO1996041874A1 (en) * 1995-06-12 1996-12-27 Kansas State University Research Foundation Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection

Also Published As

Publication number Publication date
WO1998040097A3 (en) 1999-01-14
NZ337702A (en) 2001-05-25
CN1250380A (zh) 2000-04-12
JP2001519781A (ja) 2001-10-23
WO1998040097A2 (en) 1998-09-17
EP0975360A2 (de) 2000-02-02
DK0975360T3 (da) 2006-11-27
KR100531491B1 (ko) 2005-11-28
AU6346598A (en) 1998-09-29
ES2270508T3 (es) 2007-04-01
KR20000075775A (ko) 2000-12-26
DE69835424D1 (de) 2006-09-14
AU725439B2 (en) 2000-10-12
CA2231591A1 (en) 1998-09-10
BR9808226A (pt) 2000-05-16
EP0975360B1 (de) 2006-08-02
DE69835424T2 (de) 2007-02-08
CN1283315C (zh) 2006-11-08

Similar Documents

Publication Publication Date Title
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
ATE264691T1 (de) Newcastle-krankheitsvirus-kombinationsimpfstoff
NO991524L (no) Vaksiner
NO982497D0 (no) Vaksine-sammensetninger for inntak gjennom nesen
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
DE69837209D1 (de) Zusammensetzungen und methoden zur systemischen verabreichung von oralen impfstoffen und therapeutischen wirkstoffen
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
ATE425253T1 (de) Tribonektine
AU7814498A (en) Multivalent (in ovo) avian vaccine
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
DE69835424D1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
HUP0000362A2 (hu) Madár-reovírusok új antigén osztálya
AU2001258373A1 (en) Method for identifying helicobacter antigens
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
DK1141305T3 (da) Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum
DE69738641D1 (de) Lebend-impfstoff gegen heliobacter pylori
HUP9801572A2 (hu) Chlamydia-vakcinák
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
WO1999020305A8 (en) Veterinary vaccines
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
SE9702241D0 (sv) Vaccine compositions IV

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975360

Country of ref document: EP

REN Ceased due to non-payment of the annual fee